Veritex Holdings (VBTX) Prices 3.95M Share Offering at $38/sh

Veritex Holdings, Inc. (Nasdaq: VBTX), the parent holding company of Veritex Community Bank, announced the pricing of an underwritten public offering of 3,947,369 shares of its common stock at a price to the public of $38.00 per share, for gross proceeds of approximately $150 million. The net proceeds to the Company, after deducting the underwriting discounts but before deducting the estimated offering expenses payable by the Company, are expected to be approximately $141.8 million. The Company has granted the underwriters a 30-day option to purchase up to an additional 592,105 shares of Company common stock at the public offering price, less the underwriting discount.

Keefe, Bruyette & Woods, A Stifel Company and Goldman Sachs & Co. LLC are serving as the joint book-running managers for the offering, and Raymond James & Associates, Inc. is acting as passive book-running manager.

The Company intends to use the net proceeds of this offering for general corporate purposes and to support its continued growth, including investments in Veritex Community Bank and future strategic acquisitions.

The Company expects to close the offering, subject to customary conditions, on or about March 8, 2022.

Additional Information Regarding the Offering

The offering of the common stock is being made pursuant to an effective shelf registration statement (File No. 333-250203) filed by the Company with the Securities and Exchange Commission (“SEC”) on November 19, 2020, and only by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement has been filed with the SEC to which this communication relates. Prospective investors should read the preliminary prospectus supplement and the accompanying prospectus and other documents the Company has filed with the SEC for more complete information about the Company and the offering. These documents are available at no charge by visiting the SEC’s website at www.sec.gov. When available, copies of the preliminary prospectus supplement, the prospectus supplement and the accompanying prospectus related to the offering may be obtained by contacting: Keefe, Bruyette & Woods, A Stifel Company by telephone at (800) 966-1559 or by e-mail at [email protected], or Goldman Sachs & Co. LLC by telephone at (866) 471-2526 or by e-mail at [email protected].

You May Also Be Interested In

• TWO to repurchase $115M in senior notes after CrossCountry merger
• Yarrow Bioscience prices $150M public offering at $26 per share
• Cosmos Health unit secures 2.5M-unit drug manufacturing deal with Viofar